Cann Group Limited (ASX:CAN)
0.0050
0.00 (0.00%)
Sep 11, 2026, 12:51 PM AEST
Cann Group Revenue
In the fiscal year ending June 30, 2026, Cann Group had annual revenue of 9.65M AUD, down -27.17%. Cann Group had revenue of 5.13M in the half year ending June 30, 2026, a decrease of -43.23%.
Revenue
9.65M
Revenue Growth
-27.17%
P/S Ratio
0.86
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.30M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 9.65M | -3.60M | -27.17% |
| Jun 30, 2025 | 13.25M | -5.11M | -27.81% |
| Jun 30, 2024 | 18.36M | -2.28M | -11.03% |
| Jun 30, 2023 | 20.63M | 9.40M | 83.61% |
| Jun 30, 2022 | 11.24M | 2.67M | 31.16% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 131.16M |
| ECS Botanics Holdings | 21.02M |
| IDT Australia | 20.38M |
| Elixinol Wellness | 15.90M |
| Epsilon Healthcare | 13.58M |
| Peak Processing | 12.51M |
| Syntara | 6.93M |
| BPH Global | 3.44M |